Atom Bioworks

Atom Bioworks is a US-based biotechnology company leveraging artificial intelligence to design and develop novel aptamer-based therapeutics and targeted delivery systems. The company's core platform, AptaBLE (Aptamer Binding LanguagE), uses transformer-based machine learning to decode protein-aptamer interactions, enabling the rapid generation of high-affinity, nuclease-resistant aptamers for targeting previously 'untargetable' proteins.